Fri, January 8, 2021
Thu, January 7, 2021
Wed, January 6, 2021
Tue, January 5, 2021
Mon, January 4, 2021
Thu, December 31, 2020
Wed, December 30, 2020
Tue, December 29, 2020
Mon, December 28, 2020
Wed, December 23, 2020
Tue, December 22, 2020
Mon, December 21, 2020
Sun, December 20, 2020
Fri, December 18, 2020
Thu, December 17, 2020

Kevin DeGeeter Initiated (TSHA) at Buy on, Jan 5th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. eeter-initiated-tsha-at-buy-on-jan-5th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Kevin DeGeeter of Oppenheimer, Initiated "Taysha Gene Therapies, Inc." (TSHA) at Buy on, Jan 5th, 2021.

Kevin has made no other calls on TSHA in the last 4 months.



There are 4 other peers that have a rating on TSHA. Out of the 4 peers that are also analyzing TSHA, 0 agree with Kevin's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Kevin


  • Biren Amin of "Jefferies" Initiated at Strong Buy and Held Target at $34 on, Monday, October 19th, 2020
  • Gbola Amusa of "Chardan Capital" Initiated at Strong Buy and Held Target at $45 on, Monday, October 19th, 2020
  • Matthew Harrison of "Morgan Stanley" Initiated at Buy on, Monday, October 19th, 2020
  • Salveen Richter of "Goldman Sachs" Initiated at Strong Buy and Held Target at $31 on, Monday, October 19th, 2020

Publication Contributing Sources